Holliston, MA, United States of America

Inna Shcherbakova

This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignee: Myeloid Therapeutics, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inna Shcherbakova. Retrieved from https://idiyas.com/inventor/inna-shcherbakova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inna Shcherbakova: Innovator in Genomic Integration

Introduction

Inna Shcherbakova is a prominent inventor based in Holliston, MA (US). She has made significant contributions to the field of genomic integration, holding two patents that showcase her innovative work. Her research focuses on methods and compositions that enhance the integration of transgenes into target genomes.

Latest Patents

Inna's latest patents include groundbreaking methods and compositions for genomic integration. These patents detail techniques for modulating a target genome and achieving stable integration of a transgene of interest into the genome of a cell. Her work is pivotal in advancing genetic engineering and therapeutic applications.

Career Highlights

Inna Shcherbakova is currently associated with Myeloid Therapeutics, Inc., where she continues to push the boundaries of genomic research. Her expertise and innovative approach have positioned her as a key figure in her field.

Collaborations

In her career, Inna has collaborated with notable colleagues, including Daniel Getts and Yuxiao Wang. These partnerships have further enriched her research and contributed to the success of her projects.

Conclusion

Inna Shcherbakova is a trailblazer in the realm of genomic integration, with her patents reflecting her dedication to innovation. Her work at Myeloid Therapeutics, Inc. and collaborations with esteemed colleagues underscore her impact on the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…